E. coli bacteria study may provide clues about drug resistance

NewsGuard 100/100 Score

Swapping a single amino acid in a simple bacterial protein changes its structure and function, revealing the effects of complex gene evolution, finds a new study published in the journal eLife. The study-;conducted using E. coli bacteria-;can help researchers to better understand the evolution of transporter proteins and their role in drug resistance.

We were quite surprised by how minor mutations can influence the structure and function of transporter proteins.

Nate Traaseth, associate professor of chemistry at New York University and the study's senior author

Cells are bound by a thin membrane layer that protects its interior from the outside environment. Within this layer are transporter proteins that control which substances are allowed in and out of the cell. These transporters actively move substances across the cell membrane by loading cargo on one side of the layer, then changing their structure to release it on the other side.

Membrane transporters are typically made up of multiple repeating units. In more complex transporters, the genetic sequence for each of these structural units is fused together into a single gene that codes for the protein.

It is thought that the repeated pattern evolved from smaller membrane protein genes that had duplicated and fused together. But are there evolutionary advantages to having more complex transporters being produced from a single, fused gene?

To investigate this, Traaseth and colleagues Maureen Leninger and Ampon (Callie) Sae Her in NYU's Department of Chemistry examined a simple transporter found in E. coli bacteria, which is plentiful in human and animal intestines. However, some strains of E. coli can cause serious illness and are increasingly resistant to antibiotics, which occurs when they pump out toxic compounds using transporters in their membrane. The E. coli transporter, called EmrE, contains two identical protein subunits that work together to move toxic molecules across the membrane and eliminate them from the cell.

Experiments revealed that changing a single amino acid-;the building blocks that make up proteins-;in one of the two protein subunits to make them slightly different from each other dramatically modified the transporter's structure and function. The subtle amino acid swap disrupted the balance of inward- and outward-facing proteins.

Importantly, changing the single amino acid altered the transporter's ability to remove toxic chemicals from E. coli and reduced the bacteria's resistance to drugs-;which may have future implications for drug development and combating antibiotic resistance.

"While the clinical application of these findings is a few steps away, understanding the evolution of drug transporters gives us new insight into how Mother Nature may harness mutations to provide drug resistance," said Traaseth.

The researchers note that the effects of a minor change to one of the identical halves of the EmrE transporter demonstrates how sensitive membrane transporters are to mutations.

"This observation could also help explain why evolution favored more complex transporters comprised of fused genes in which single amino acid changes can alter how the transporter operates," added Traaseth.

Source:
Journal reference:

Leninger, M. et al. (2019) Inducing conformational preference of the membrane protein transporter EmrE through conservative mutations. eLife. doi.org/10.7554/eLife.48909

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Targeting skin microbiome rivals: Unveiling epilancin A37's antimicrobial mechanism